Anticoagulation therapy in diabetic patients

Loading...
Thumbnail Image

Authors

Wessels, Pieter Frederik

Journal Title

Journal ISSN

Volume Title

Publisher

Clinics Cardiv

Abstract

Diabetic patients have a high risk of developing arterial disease (coronary artery, cerebrovascular and peripheral arterial disease) and are therefore often given antiplatelet therapy. Although only retrospective studies suggest that diabetic patients are also prone to venous thrombo-embolism, many comorbid factors in the diabetic patient, such as heart failure, physical inactivity and atrial fibrillation increase the risk of venous thrombosis. A recent sub-analysis of the RECORD study examined the risk of hyperglycaemia during hip replacement, as a risk factor for postoperative venous thrombo-embolism. For these reasons, diabetic patients are also often given anticoagulant therapy.

Description

Keywords

Anticoagulation therapy, Diabetic patients, Vascular disease, Atrial fibrillation (AF)

Sustainable Development Goals

Citation

Wessels, PF 2012, 'Anticoagulation therapy in diabetic patients', South African Journal of Diabetes and Vascular Disease, vol. 9, no. 1, pp. 7-8.